Characterization of Braun's lipoprotein and determination of its attachment sites to peptidoglycan by 252Cf-PD and MALDI time-of-flight mass spectrometry  by Pittenauer, Ernst et al.
Characterization of Braun’s Lipoprotein 
and Determination of its Attachment 
Sites to Peptidoglycan by 252Cf-I?D 
and MALDI Time-of-Flight Mass Spectrometry 
Ernst Pittenauer,” Jo2 Carlos Quintela, ’ Erich R. S&mid, and Giinter 
Allmaier 
Institute for Analytical Chemistry, University of Vienna, A-1090 Vienna, Austria 
Gerd Paulus 
Shimadzu Europe, D-47269 D&burg, Germany 
Miguel A. de Pedro 
Centro de Biologia Molecular “Sever0 Ochoa,” C.S.I.C., Unwersldad Aut6noma de Madrid, 
E-28049 Madrid, Spain 
A strategy for the characterization of bacterial lipoprotein in this case Braun’s lipoprotein 
(an outer membrane 7-ku lipoprotein) isolated from Escherichia coli-is described by time- 
of-flight mass spectrometric (TOF/MS) techniques [ 252Cf plasma desorption (I’D) TOF/MS 
and matrix-assisted laser desorption-ionization (MALDI) TOF/MS]. Covalent linkage of 
lipid at the N-terminal cysteine (posttranslationally modified to a S-[2,3-bis(acyloxy)-propyl]- 
N-acylcysteine) and, therefore, strict insolubility in aqueous solution constitute common 
features for this class of proteins. Relative molecular mass determination of the major 
molecular species of Braun’s lipoprotein was obtained by selection of an appropriate mixture 
of organic solvents compatible with matrix/support materials useful for the mass spectro- 
metric techniques applied. Minor components of this lipoprotein that differ only in the fatty 
acid composition of the lipid anchor were detected by PD TOF/MS after enzymatic release of 
the extremely hydrophobic N-terminal amino acid followed by selective extraction with 
chloroform. Part of the primary sequence of this lipoprotein was confirmed based on peptide 
fragment ions observed in the positive ion PD mass spectra of cyanogen bromide-generated 
peptide fragments that had been isolated previously by reverse phase high-performance 
liquid chromatography (HPLC). Peptidoglycan fragments that represent the attachment sites 
of lipoprotein to peptidoglycan were enzymatically released, separated by reverse phase 
HPLC, and finally characterized by time-of-flight mass spectrometric techniques (‘“*Cf-PD 
TOF/MS, MALDI TOF/MS). The results obtained with both techniques differed only in the 
better sensitivity obtained with MALDI TOF/MS, which consumed a factor of 100 to 1000 
less material than with I’D TOF/MS. (J Am Sot Muss Spectrom 2995, 6, 892-905) 
B acterial lipoproteins constitute a class of strongly hydrophobic, water-insoluble membrane pro- teins, whose N-terminal amino acid cysteine is 
posttranslationally modified to a S-[2,3-bis(acyloxy)- 
propyll-N-acylcysteine residue [ 11. These membrane 
proteins occur in the free form as well as covalently 
linked to the peptidoglycan layer as commonly ob- 
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served among Gram-negative Enterobacteriaceae. Pep- 
tidoglycan itself represents a giant macromolecule 
that consists of long glycan strands of alternating l/3 
+ 4-linked N-acetylglucosamine (G~cNAc) and N- 
acetylmuramic acid (MurNAc) units with short pep- 
tide side chains (that typically contain 2-5 amino 
acids) linked to the MurNAc residue and that ter- 
minate with a 1,6-anhydro-MurNAc residue [2]. The 
complete three-dimensional shape of peptidoglycan 
is provided by cross-linkage of peptide side chains of 
different glycan strands to form a water-insoluble 
network surrounding the cytoplasmic membrane. 
When peptidoglycan is digested with a muramidase 
(e.g., lysozyme, Chalaropsis muramidase, etc.) to obtain 
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water-soluble peptidoglycan fragments, the carbohy- 
drate copolymer is cleaved into disaccharide units that 
retain their peptide side chains. Where a peptide side 
chain is not cross-linked to another peptide side chain, 
the resulting digest product corresponds to a disaccha- 
ride peptide and is therefore termed peptidoglycan 
monomer (e.g., a disaccharide tripeptide will then be 
called “Tri”). I f  such a monomer building block is 
cross-linked via a peptide bond to another monomer, 
the resulting muramidase digest product would be a 
bis-disaccharide peptide and, therefore, called peptido- 
glycan dimer. Examples of chemical structures of pep- 
tidoglycan monomers, dimers, and one trimer that 
occurs in muramidase digests of the peptidoglycan of 
Esckerickia coli are given in Figure 1. 
The bound form of such lipoproteins from Enter- 
obacteviaceae is usually linked to the diamino acid (i.e., 
diaminopimelic acid) of disaccharide tripeptide units 
(compare compound 2 in Figure 1). Among other Gram- 
negative and also Gram-positive bacteria, lipoproteins 
have been detected only in the free form that is not 
covalently linked to any other biopolymer [I]. The 
biological functions and properties of these lipopro- 
teins include maintenance of the outer membrane 
structure, nutrient transport svstems, and a wide vari- 
ety of different enzymatic activities as well as several 
different immunological reactions in animals and hu- 
man beings [I]. A growing interest in pharmaceutical 
research for vaccines against bacterial infections is due 
to these immunological properties; thus, for example, 
there is an interest in the outer surface protein A 
1 1 ; 1 
L-Aq mA,pmcD-Ala 
2 D-Ala 
5 
GkNAc-MwNAc GICNACP-MMNAC MwNAcMkNAc 
GkNAc-+MuNAc 
1 
L-A!3 
1 1 
LAla 
1 1 
L-Ala 
L-Ala D-fGlU 
1 1 
1 1 
D-yGlU D-+X 
D-fGlu 
1 1 m&pm 
1 1 
m4,pm-mA,pm 
1 
mAlpmcD-Ala DA!3 
3 4 
Figure 1. Chemical structures of some major “peptidoglycan” 
fragments (monomer, dimer, trimer) obtained by consecutive 
digestion of E. coli peptidoglycan with pronase E and Chalnropsis 
muramidase. The structures exhibit unusual alternating L- and 
D-configured amino acids, unusual linkage for the glutamic acid 
residues as well as cross linkage of peptide side chains. Examples 
include the monomers 1 (Tetra) and 2 (Tri-Lys-Arg, one pronase 
E digestion product of lipoprotein linked to peptidoglycan), two 
isomeric dimers 3 (Tetra-Tri, D-Ala -+ D-A2 pm cross linked) 
and 4 (Tetra-Tri, L-A,pm + D-A,pm cross linked), and the 
trimer 5 (Tetra-Tetra-Tetra). 
(OspA) from Borreiia burgdorferi, a bacterium that is 
known to cause Lyme disease. Recently, lipid-linked 
OspA (but not the lipid-free protein) was shown by 
Erdile et al. [3] to induce a protective response and 
serum immunoglobulin against B. burgdorferi infec- 
tions. Braun and co-workers [4-81 reported first on an 
outer membrane 7-ku protein from E. coli [4]; they 
described its covalent linkage to peptidoglycan [5, 61, 
its primary sequence [7, 81, and the covalent binding of 
a diacylglycerol moiety [9]. Further, Inouye et al. [lo] 
and Hirashima et al. [ll] recognized that only one 
third of this 7 ku lipoprotein is covalently linked via 
the &-NH, group of the C-terminal lysine to the cy- 
COOH group of the diaminopimelic acid residue of 
tripeptide side chains of peptidoglycan. The remaining 
two thirds of this lipoprotein is in the free form. 
Inouye [12] described a model for three-dimensional 
molecular assembly of this lipoprotein to form hexam- 
eric to octameric protein tubular channels that pene- 
trate the outer membrane. 
These two forms of outer membrane 7-ku lipopre 
tein are both known as Braun’s lipoprotein. In addi- 
tion, a so-called peptidoglycan-associated lipoprotein 
(PAL) that has a molecular weight of 21 ku was de- 
scribed from E. coli present in close association with 
peptidoglycan but not covalently bound to it [13, 141. 
Later, Ichihara et al. 1151 reported on seven new 
lipoproteins localized either in the outer membrane or 
in the cytoplasmic membrane of E. coli; the molecular 
weights ranged from 16 to 52 ku as determined by 
sodium dodecyl sulfate (SDS)-polyacrylamide gel elec- 
trophoresis. Among these nine different lipopro- 
teins known from E. coli, only the smallest, the 7-ku 
lipoprotein, occurs in both the free and the peptidogly- 
can-bound form. During preparation of peptidoglycan 
from E. coli to obtain water-soluble fragments for 
high-performance liquid chromatography (HPLC) 
analysis, the bound form of Braun’s lipoprotein must 
be degraded by digestion with pronase E, which leaves 
the C-terminal end Arg-Lys at tripeptide subunits. 
These degradation products appear as water-soluble 
Lys-Arg-containing peptidoglycan fragments [ 16, 171 
in HPLC chromatograms that indicate the various at- 
tachment sites of this lipoprotein to peptidoglycan. 
We have previously used reverse phase HPLC in 
“off-line” combination with 252Cf plasma desorption 
time-of-flight mass spectrometry (252Cf-PD TOF/MS) 
to study native [l&20] and biosynthetically modified 
peptidoglycan preparations from E. coli [21], the pepti- 
doglycan structure of the cyanelles from Cyanopkora 
yaradoxa [ 22, 231, the peptidoglycan from the cyanobac- 
terium Synecocystis spec. strain PCC 6714 [24], and the 
peptidoglycan from the thermophile bacterium Tker- 
nzz4s tkernzopkilus [24b]. In these investigations we 
adapted the nitrocellulose adsorption technique, origi- 
nally described for peptides and proteins [25], to the 
analysis of strongly hydrophilic, muramidase-released 
peptidoglycan fragments [26]. A rinsing procedure is 
absolutely necessary to remove salt contaminations 
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(especially sodium and potassium cations, which are 
commonly associated with such hydrophilic glycocon- 
jugates even after extensive chromatographic purifica- 
tion) and to eliminate interference with the relative 
molecular mass determination of unknown com- 
pounds. Rinsing procedures up to several 100 PL of 
solvent are only tolerated by analytes strongly ad- 
sorbed onto nitrocellulose, which is not the case for 
most peptidoglycan fragments. Therefore we devel- 
oped a sample preparation technique, the so-called 
“nitrocellulose sandwich technique” [26], in which the 
hydrophilic analyte is sandwiched between two lavers 
of nitrocellulose prior to microrinsing; this allows se- 
lective removal of salt contaminations even for very 
hydrophilic compounds without dramatic sample loss. 
As an extension of our investigations on different 
peptidoglycans we sought to establish a method for 
the mass spectrometric characterization of compounds 
covalently linked to peptidoglycan, in particular, the 
lipoproteins of Gram-negative bacteria. The water- 
insolubility of these proteins poses a number of techni- 
cal difficulties whose solution also could probably 
apply to other families of hydrophobic proteins and 
peptides. As a model system we chose Braun’s lipo- 
protein from E. coli because extensive knowledge of 
this protein facilitates a critical evaluation of the accu- 
racy and reliability of the methods applied. In this 
paper we describe a strategy that uses two different 
time-of-flight mass spectrometric techniques for the 
analysis of the free form of Braun’s lipoprotein and its 
isolated N-terminal lipid anchor. We also describe the 
determination of peptidoglycan attachment sites of the 
bound form of this lipoprotein. Results obtained by 
252Cf-PD TOF/MS are compared with data obtained 
with matrix-assisted laser desorption-ionization mass 
spectrometry (MALDI TOF/MSl. Special emphasis in 
MALDI mass spectrometry was also given to an ap- 
propriate sample preparation technique due to the 
specific properties of these different classes of com- 
pounds (lipoproteins, lipids, glycopeptides). The ex- 
perimental approach presented in this paper also may 
have a rather wide interest to protein chemists because 
it should be of direct and general applicability to the 
analysis of bacterial lipoproteins and peptidogly- 
can--lipoprotein complexes. 
Experimental 
vested by centrifugation and were stored frozen at 
-70 “C until used. 
lsolrztion and Purification of the Free Form of 
Braun’s Lipoprotein 
The free form of Braun’s lipoprotein was purified by a 
modification of the procedure described by Inouye et 
al. [28]. After the second acetone precipitation the 
lipoprotein pellet was resuspended in 0.01-M ethylene- 
diaminetetraacetic acid (EDTA), 1% SDS in 0.01-M 
sodium phosphate buffer pH 7.0, and further purified 
by gel filtration chromatography on a Sephadex G-100 
Superfine column (Pharmacia LKB Biotechnology AB, 
Uppsala, Sweden). The column (32 X 2.5 cm) was 
equilibrated and eluted with the same buffer at a flow 
rate of 12 mI,/h. Fractions (1 mL) were collected and 
the protein content of every fraction was determined 
by bicinchoninic acid (BCA) protein assay (Pierce, 
Rockford, IL) that measured the absorbance at A = 562 
nm. Every fraction also was tested for the presence of 
Braun’s lipoprotein by SDSpolyacrylamide gel elec- 
trophoresis. All fractions that contained this lipopro 
tein were pooled. Final removal of salts and SDS was 
performed by precipitation with acetone. The final 
pellet was lyophilized and stored at -20 “C. 
Cyanugen Bromide Cleavage of the Free Form of 
Braun’s Lipoprotein 
Purified lipoprotein (20 mg) was dissolved in 15 mL of 
formic acid (Merck, Darmstadt, Germany) that con- 
tained 20% ultrapure water obtained from a MilliQ 
plus aperture (Millipore, Millford, MA; conductivity, 
18.2 MiZ/cml to which finally 600 mg of colorless 
cyanogen bromide (Merck) was added. The cleavage 
was performed under a nitrogen atmosphere in the 
dark at room temperature for 24 h at 20 “C. The 
cleavage reaction was terminated by evaporation to 
dryness via a Univapo vacuum centrifuge (Univapo, 
Martinsried, Germany). Separation of the water- 
insoluble fraction, which contained mainly the N- 
terminal lipopeptide, from the water-soluble fraction 
was performed by the addition of 5 mL of ultrapure 
water to the dried cleavage products and centrifuga- 
tion at 10.000 g for 10 min. Both fractions were sepa- 
rately dried by lyophilization. 
Bacterial Strains and Growth Conditions HPLC Separation of the Water-Soluble Peptides 
E. co/i MC6 RI’1 (K12, F , proA IeuA thr dra drm 1ysA 
Released by Cyanogen Bromide Cleavage of the Free 
thil [27] was grown aerobically to the late exponential 
Form cf Braun’s Lipoprotein 
phase in a medium composed of commercially avail- Approximately 100 pg of the water-soluble peptides of 
able tryptone (10 g/L), yeast extract (5 g/L), sodium the cyanogen bromide digest were separated by HPLC 
chloride (5 g/L), magnesium sulfate (1.2 g/L), and by using a Spectra-Physics SP8100XR extended range 
glucose (3.6 g/L) in a 200-l. fermenter at pH 6.8. liquid chromatographer (Spectra Physics Analytical, 
Growth of the bacteria was monitored by measuring Fremont, CA) connected to a Spectra Physics SP 4270 
the optical density at A = 5.50 nm. Cells were har- integrator and a Millipore Waters Lambda-Max Model 
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481 liquid chromatography (LC) spectrophotometer 
(Millipore Waters, Millford, MA). The stationary phase 
was Hypersil ODS (Shandon, Runcorn, UK) with 3-Frn 
particle size packed in a 250 X a-mm column 
(Teknochroma, Barcelona, Spain). The mobile phase 
consisted of 0.1% trifluoroacetic acid in ultrapure wa- 
ter as solvent A and acetonitrile (Scharlau, Barcelona, 
Spain) and ultrapure water (7:3) that contained O.lCic 
trifluoroacetic acid as solvent B. The column tempera- 
ture was maintained at 25 “C and the flow rate was 0.5 
mL/min. The detection wavelength A was 214 nm. 
The gradient was linear from 0 to 50% solvent B (O-50 
min) and then from 50 to 100% solvent B (5Om 75 min). 
Manually collected fractions ot interest were immedi- 
ately evaporated to dryness and kept at -20 “C until 
further use. 
vent used was 100% solvent A for 7 min, then a 
gradient from 0 to 100% solvent B (7-122 min), and 
finally 100% solvent B (122-150 min). The flow rate 
was 0.5 mL/min and the column temperature was 
40 “C. The detection wavelength was 210 run. Prelimi- 
nary identification of Lys-Arg-containing peptidogly- 
can fragments was based on comparing HPLC profiles 
of the native peptidoglycan fragment mixture, fraction 
1 and fraction 2 (all sodium borohydride-reduced). 
Only peaks that appear in the native mixture and in 
fraction 2, but not in fraction 1, were selected as 
possible candidates for Lys-Arg-containing peptido- 
glycan fragments. 
isolation of the Posttranslationally Modified 
Cys teine of Bmun’s Lipoprotein 
Isolation and Purificatio~l of the Bound Form of The intact purified free form of Braun’s lipoprotein 
Braun’s Lipoprotein and Subsequent Purification c?f 
was resuspended in lo-mM Tris (Merck) buffer pH 7.2 
Lys-Arg-Containing Peptido~glycun Fruxments 
and digested with preactivated pronase E for 12 h 
(enzyme to substrate ratio, 1:l). Final extraction of the .- _” 
Peptidoglycan from E. co/i MC6 RI’1 was purified 
extremely hydrophobic lipid anchor (= S-[2,3- 
following standard procedures [16, 171 by consecu- 
bis(acyloxy)-propyl-]-N-acylcysteine) was performed 
tive digestion with cu-amylase tvpe II-A from Baci/lus by direct extraction of the enzymatic digest solution 
spc. (Sigma, St. Louis, MO) and muramidase from 
with chloroform (Merck). For the plasma desorption 
Chalaroysis spec. as reported [29] except that pronase E 
(I’D1 mass spectrometric analysis the extracted lipid 
was used previously. By treatment of the intact pepti- 
anchor was used without further purification. 
do&can with muramidase, all peptidoglycan frag- 
-  .  ._ W I  \ ,  
ments not attached to lipoprotein are solubilized in 
water (fraction 1). This fraction therefore is separated 
‘j2Cf Plasma Desorption Time-of-Flight 
easilv from the water-insoluble fraction that includes 
Mass Spectrometry 
lipoprotein-attached peptidoglycan fragments as well 
as the remaining undigested peptidoglycan. To remove 
the undigested peptidoglycan, the pellet was boiled in 
5% SDS solution to dissolve the bound form of the 
lipoprotein (fraction 2). After centrifugation at 10.000 g 
for 20 min sufficient acetone was added to the super- 
natant to precipitate purified lipoprotein again. The 
lipoprotein pellet was resuspended three times in wa- 
ter to remove remaining SDS and finally lyophilized. 
To obtain almost all of the Lys-Arg-containing pepti- 
doglycan fragments that occur in sufficient amount, 
fraction 2 was subsequently digested with preactivated 
pronase E from Streptovryce~ griscus (Merck) by sus- 
pension of the analyte in IO-mM Tris (Merck) buffer 
pH 7.2. To the resulting mixture of soluble LysArg- 
containing peptidoglycan fragments, a sodium borate 
buffer pH 8 was added and reduction was carried out 
using sodium borohydride (Merck) for 30 min. The 
reaction was stopped by adjusting the pH of the reac- 
tion mixture to 4 by the addition of concentrated 
phosphoric acid (Merck). 
Finally, the peptidoglycan fragments were purified 
from pronase E degradation products by using the 
same HPLC equipment as described previously with 
the following mobile phases: solvent A, 50-mM sodium 
phosphate pH 4.35; solvent B, 75mM sodium phos- 
phate pH 4.95 that contained 15% methanol. The so- 
All analyses were performed on a BioIon 20 plasma 
desorption time-of-flight mass spectrometer (BioIon, 
Uppsala, Sweden) fitted with a standard linear flight 
tube (150 mm) and lo-PCi 2.i2Cf ion source. Due to 
sufficient adsorption properties of most compounds 
investigated, nitrocellulose (BioRad, Richmond, CA) 
was used as support material [25]. Approximately 100 
/“g of nitrocellulose dissolved in acetone (1 pg/pL) 
was electrosprayed onto aluminized Mylar targets. All 
positive-ion I’D mass spectra were obtained at an 
accelerating voltage of 1-20 kV and a time resolution 
of 1 ns per channel. Intact lipoprotein and the cyanogen 
bromide-generated N-terminal lipopeptide samples 
were adsorbed from a solution that contained formic 
acid:water:methanol:2-propanol = 5:15:40:40, similar to 
the solvent system described by Bouchon et al. [30] for 
electrospray ionization mass spectrometry (ESI/MS). 
Water-soluble cyanogen bromide-generated peptide 
fragments and peptidoglycan fragments were ad- 
sorbed from aqueous 0.1% trifluoroacetic acid solu- 
tions. Spectrum acquisition times were 2 X lo7 pri- 
mary events for the intact lipoprotein samples and 
5 x 10h primary events for the cyanogen bromide- 
generated peptides as well as for all types of peptid- 
oglycan fragments. Prior to analysis all samples where 
rinsed with 3 x 100 PL (in the case of the intact 
lipoprotein and peptide fragments) or 3 X 10 /IL (in 
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the case of peptidoglycan fragments) of 0.1% trifluo- 
roacetic acid in ultrapure water to remove interfering 
alkali cations and other low mass contaminants. The 
free form of Braun’s lipoprotein and the cyanogen 
bromide-derived N-terminal lipopeptide were also in- 
vestigated by using 9-anthroic acid (Fluka, Buchs, 
Switzerland) and 3-(3-indolyl) acrylic acid (Sigma) ma- 
trix (Pittenauer, E. et al., manuscript in preparation). 
The advantage of this matrix compared to nitrocellu- 
lose support has been reported [31] to be a lesser 
internal energy of desorbed/ionized molecules that 
results in decreased metastable decompositions during 
the flight and therefore in improved peak shapes of 
protonated ions. Interestingly, this matrix recently was 
described by Chou et al. [32] as a useful matrix for 
MALDI mass spectrometry of dynorphin peptides. Ap- 
proximately 210&300 PL of a solution of 9-anthroic 
acid (ACA) or 3-(3-indolyl) acrylic acid (IAA) in ace- 
tone (each 1 kg/pL) was electrosprayed onto alu- 
minized Mylar backings. Prior to sample adsorption 
the matrix surface was rinsed with 3 X lOO-PL O.lS’r 
trifluoroacetic acid in ultrapure water. Sample adsorp- 
tion was performed from the same solvent mixture as 
for the nitrocellulose support. Prior to analysis all 
samples were rinsed with 3 X lOO-PL 0.1% trifluo- 
roacetic acid in ultrapure water. 
For the PD mass spectrometric characterization of 
the pronase E-released lipid anchor (which is soluble 
only in chloroform) nitrocellulose support, IAA and 
ACA as the matrix could not bc used due to disinte- 
gration of the support/matrix layers when this solvent 
was applied. The matrix material 3-(3-pyridyl) acrylic 
acid (PAA; Aldrich, Steinheim, Germany) recently was 
compared with nitrocellulose support and found to 
yield superior results for several different classes of 
lipids and glycolipids in positive- as well as negative- 
ion mass spectra [20, 33-351. PAA shows high surface 
stability against chloroform as an analyte solvent. Ap- 
proximately 300 PL of a saturated solution of PAA in 
acetone was electrosprayed onto an aluminized Mylar 
target. Prior to sample deposition the matrix surface 
was rinsed with 3 X 100-@L ultrapure water, Finally, a 
lo-/LL aliquot of the free lipid anchor (between 1 and 
10 pg of lipid) dissolved in chloroform was deposited 
onto the matrix surface. To remove alkali cations and 
other low mass contaminations selectively, the sample 
was rinsed with 3 x 50-PL ultrapure water prior to 
analysis. 
Matrix-Assisted Laser Desorption-ionization 
Time-of-Flight Mass Spectrometry 
Mass spectrometric measurements were performed in 
the reflector mode on a Kratos Analytical Kompact 
MALDI-III (Kratos Analytical, Manchester, UK) laser 
desorption time-of-flight instrument equipped with a 
nitrogen UV laser (A = 337 nm, 3-ns pulse width). 
Positive-ion mass spectra were obtained by signal av- 
eraging of 100 laser shots. During data acquisition the 
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shot-to-shot signal was viewed on the computer moni- 
tor as the laser was attenuated to maintain the optimal 
laser power density near threshold level (- lo6 
W/cm*). The ions were accelerated to a final potential 
of + 20 kV. Conversion of flight time to mass-to-charge 
ratio was achieved by internal calibration by using the 
[M - OH]+ peak of the matrix (m/z 207.21) and the 
[M + H]’ peak of bovine insulin. Mass assignments 
for the intact free form of Braun’s lipoprotein were 
derived from the centroided top 30% of the ion signals. 
Sample preparation was done according to the recently 
reported procedure for bacteriopsin [36] with sinapinic 
acid matrix (Sigma). Additionally, Lys-Arg-containing 
peptidoglycan fragments were measured using 2,5- 
dihydroxybenzoic acid matrix as recently described for 
a 
b 
Figure 2. Positive-ion I’D mass spectra of the free form of 
Braun’s lipoprotein from E. coli MChRPl adsorbed onto (a) 
nltrocellulose support, (b) 9-anthroic acid matrix, and (c) 3-(3-in- 
dolvl) acrylic acid matrix. 
lonlzatlon Support 
[M + HI’ /FM t 2H1’ /‘CM + 3H13 
average m/r values 
Difference between observed 
and calculated molecular 
weight expressed as I\m 
Mass 
deviation 
technique or matrix 
PD NC 
PD ACA 
PD IAA 
MALDI SA 
Calculated Found 
7202 70/ 7202 7, 
3601 85/ 3602 1 ,/’ 
2401 57 2400.8 
7202.70/ 7202.6: 
3601 85,’ 3603.4, 
2401 57 (- ) 
7202 70,: 7202 8 / 
3601.85, 3601 8;; 
2401 57 i -1 
7202 701 7203 8; 
3601 85,; 3601.2.’ 
2401 57 ( --) 
based on n types of ions 
-0 61 (n= 3) 
f1.50(n=2) 
O(n=2) 
-0.40 (n = 2) 
(%) 
- 0.0085 
~0.0208 
- 
+0.0056 
aPrlmary sequence as reporred by Braun and Bosch [7. 81 C*SSNAKIDQLSSDVQTLNAKVDQLSNDVNAMRSDVQAAKDDAARANQRLDN- 
MATKYRK, C* corresponds to the llpid~modlfled cyste~ne moiety Average calculated molecular weight IS based on the major lipid 
composttlon 18 1 ~16 O-16.0 7201 69 J by posltlve-Ion PD TOF:MS and MALDI TOF’MS Abbreviations used NC, nltrocellulose, ACA, 
9.anthrolc acrd, IAA, 3.(3-indolyl) acrylic acid, SA, sjnap~ne acid 
peptides and proteins 1371. The sample/matrix mix- 
tures were applied in the center of the disposable 
sample probe and the solvents were removed slowly 
in the system apparatus before insertion into the ion 
source. The lipid anchor did not vield any positive or 
negative quasimolecular ion when sinapinic acid or 
2$dihydroxybenzoic acid wert’ used. Application of 
the lipid anchor directly onto the probe tip without 
any matrix would most likely result in detection of a 
negative-ion cluster that corresponds to [M - COOH] 
ions. 
Results and Discussion 
Until recently molecular weight determination of 
strongly hydrophobic, water-insoluble membrane pro- 
teins was a difficult task for desorptionpionization 
mass spectrometric techniques due to the insolubility 
of these proteins in many solvents and buffers com- 
patible with mass spectrometry. Up to now only a 
few examples of molecular weight determination of 
such hydrophobic proteins as well as their cyanogen 
bromide-generated peptidc fragments have been re- 
ported (e.g., bacteriopsin and bacteriorhodopsin from 
Hniobnctcrium halobiuw and other sources by MALDI 
TOF/MS [36] and ESI/MS [38 30]; cyanogen bromide 
peptide fragments of native bacteriopsin by ESI/MS 
1411 as well as biosynthetically modified bacteriopsins 
by fast-atom bombardment mass spectrometry 
(FAB/MS) [42]; a genetically engineered 2%ku 
lipoprotein from B. b~rr@o@~i [XI] and a thermolytic 
fragment of colicin A by ESI,‘MS t-231; cyanogen bro- 
mide peptide fragments from chicken intestinal cal- 
bindin-D28” by ‘52Cf-PD TOF/MS [44]). 
Most applications of protem molecular weight de- 
termination by 25’Cf-PD TOF/MS within the last 
decade were performed via analyte adsorption onto 
nitrocellulose support from acidified aqueous solu- 
tions. So far no experiments have been reported on 
membrane protein adsorption from analyte solutions 
that contain a high percentage of organic solvents 
(> 80%) such as adsorption from alcoholic solvents 
onto support or matrix materials. (The distinction be- 
tween support and matrix materials has been made by 
Roepstorff [45].) In an attempt to solubilize Braun’s 
lipoprotein, we adopted a solvent system similar to 
that described by Bouchon et al. [30] for the ESI/MS 
analysis of the 28-ku outer surface protein A (OspA) 
from B. hryqkyfrvi. Roughly 1 nmol of lipoprotein was 
adsorbed from this high percentage alcoholic solution 
onto nitrocellulose support or onto 9-anthroic acid- or 
3-(3indolyl) acrylic acid matrix for several minutes 
without visible disintegration of the support/matrix 
surface. After an extensive rinsing procedure to re- 
[M+H]+ 
[M+2H]2+ 
Figure 3. Positive-ion MALDI mass spectrum of the free form 
(If Hraun’s lipoprotein from E. coli MC6RPl utilizing sinapinic 
acid matrix. The small peak at ~I/Z 3200 most likely corresponds 
to an unknown impurity. 
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Table 2. Chemical structure ot the major component of the isolated lipid anchor (S-[2,3-bis(acyloxy)-propyl-I-N-acylcysteine) 
released by pronase E digestion of the tree term of Braun’s lipoprotein and molecular species detected in the negative- and 
positive-ion I’D mass spectrum” 
1 935 (-Ii: thioether) 951(-H: sulfodde) YCW CO-NH-CH--CO--OH 9'=-H;s*m) 
Fatty acid composltlon 
of the S-[2,3-biscacyloxy) 
-propyl-I-N-acylcysteine 
Average 
molecular [M - HI 
[M + PAA + HI+ 
moiety weight Calculated Found Calculated Found 
16:0-16:0-16:l 908.46 907.45 907.2 1058.62 1058.8 
16:O -16:O -16:1 sulfowde 924.46 92345 923.0 1074.61 1073.5 
18:1~16:0~16:0 936.51 935.50 935.0 1086.67 1086.4 
18:l -16:O -16:O sulfoxide 952.5 1 951 50 951 .o 1102.67 1101.3 
18:1-18:1-16:O 962.55 961.54 961.0 1112.71 1114.4 
18:1 -18:l -16:O sulfoxide 978.55 977.54 977.2 1128.71 1128.3 
18.1 -18:l -16:Osulfone 994.55 993.54 992.6 1144.71 - 
aOnly boldface type corresponds to native molecules Sulfoxldes and sulfones are most probably artifacts due to cwdation during 
preparation of the lipid ancha 
move interfering alkali contaminants, positive-ion I’D 
mass spectra of good quality were obtained. The re- 
sults confirmed the calculated molecular weight based 
on the published primary sequence [7, 81 and the 
expected [9] 18:1-18:1-16:0 fatty acid composition for 
the lipid anchor as the major molecular species (see 
Figure 2aac; see also Table 1 for mass accuracies ob- 
tained with different sample preparation techniques). 
Interestingly, no triply protonated molecular ions for 
this lipoprotein were observed in the I’D mass spec- 
trum when the small molecule matrix materials 9- 
anthroic acid or 3-(3-indolyl) acrylic acid were used. 
Analysis of < 5 pmol of the intact free form of 
Braun’s lipoprotein by MALDI TOF/MS with sina- 
pinic acid as the matrix gave a comparable result with 
similar mass accuracy to I’D TOF/MS (see Figure 3 
and Table 11. 
Three factors prevented the detection of minor 
molecular species that vary in only one fatty acid 
substituent (AM = 26 for a -CH =CH- or 28 u for a 
-CH,-CH,- moiety for the fatty acid alkyl side 
chain): (1) the relatively high molecular weight of the 
lipoprotein sample; (2) a certain degree of peak broad- 
ening by metastable decay of the protonated molecular 
ions; (3) insufficient mass resolution performance of 
the available linear I’D time-of-flight instrument as 
well as the reflector MALDI time-of-flight instrument 
in the 7-ku mass range. To investigate the heterogene- 
ity of the fatty acid moieties of the lipid anchor, the 
a 1 * 
MI2 
b 30.8 
I’ 
281.5 
[M-HI- /9035.O 
M/Z 
Figure 4. (a) Positive- and (b) negative-ion I’D mass spectra of 
the pronase E-released isolated lipid anchor (S-[2,3-bis(acyloxy)- 
propvl-]-M-acylcysteine) deposited onto 3-(3-pyridyl) acrylic acid 
matrix. Asterisks (*) correspond to PAA matrix cluster ions. 
intact free form of Braun’s lipoprotein was digested 
with pronase E to achieve nonspecific hydrolysis of all 
L,L-configured peptide bonds of the protein and to 
leave mainly free amino acids. Only the N-terminal 
amino acid cyst&c covalently linked to the lipid moi- 
ety exhibited superior solubilitv in chloroform to allow 
direct and selective extraction-of the lipid anchor into 
the organic solvent phase. The crude chloroform ex- 
tract was analyzed without further purification by 
positive- and negative-ion I’D TOF/MS. 3-(3-Pyridyl j 
acrylic acid was selected as the matrix for this diglyc- 
eride thioether lipid because of strong chemical simi- 
larities to glycerol ester-based lipids and phos- 
pholipids that have been successfully analyzed by 
utilizing this matrix [33-351. In the positive-ion I’D 
mass spectrum no protonated molecular ion peaks 
could be detected due to the absence of any strong 
protonation site in the molecule (Figure 4a). Instead, 
abundant adduct ions with PAA matrix of the type 
[M + PAA + HI+ that showed no significant fragmen- 
tation were detected. The very broad peak cluster 
centered around nr/~ 950 corresponds most likely to 
metastable ions of the [M + I’AA + H] ’ adduct ions 
and represents ions with UI/Z values not directly 
correlated with any protonated molecular ion or frag- 
ment ion. In the negative-ion I’D mass spectrum of the 
lipid anchor (Figure 4b) very abundant deprotonated 
molecular ions were formed: W/Z 907.2, 16:0-~ 
Figure 5. Positive-ion PD mass spectra of the water-insoluble 
cyanogen bromide-released N-terminal lipopeptide CNBr 1 from 
the outer membrane 7-ku lipoprotein adsorbed onto (a) nitrocel- 
lulose support and (b) 9-anthroic acid matrix 
16:0-16:l; m/z 935.0, 18:1-18:1-16:0, and m/z 961.0, 
18:1-18:1-181 are observed as major components. Fur- 
thermore, abundant fatty acid fragment anions at m/z 
281.5 (18:1, cis-vaccenate) and m/z 255.3 (X:0, palmi- 
tate) correlated with the major fatty acid constituents 
of the lipid anchor were detected [9]. 
Additionally, as the result of digestion of Braun’s 
lipoprotein with pronase E at roughly neutral pH con- 
ditions, partial oxidation of this native mixture of 
homologous compounds takes place at the thioether 
moiety to the corresponding sulfoxide and sulfone 
derivatives, respectively, of the S-[2,3-bis(acyloxy)- 
propyll-N-acylcysteines (see Table 2). No mass shift by 
+ 16 and + 32 u, respectively, of the protonated molec- 
ular ion of the intact free form of this lipoprotein was 
observed in the positive-ion I’D mass spectrum (com- 
pare Figures 2 and 3). 
MALDI mass spectrometry failed to give any use- 
ful results in either ionization mode with either 2,5- 
dihydroxybenzoic acid or sinapinic acid. Only in the 
absence of any UV-absorbing matrix material could a 
negative-ion MALDI mass spectrum be obtained where 
detected negative ions corresponded most likely to 
decarboxylated lipid anchor anions (data not shown) 
a 329(h----- 
j 
IM+Hl+ 2298 7 
[M+2HI2+ 
i w 
M/Z 
b 1766 
[.M+HJ+ 766 7 
! [M+2H]2+ 
I 
* 
h ._ .h 
Figure 6. Positive-ion PD mass spectra of the water-soluble and 
reverse phase HPLC-separated cyanogen bromide-released pep- 
tides from the free form of Braun’s lipoprotein representing (a) 
CNBr 2 and (b) CNBr 3, both adsorbed onto nitrocellulose 
support. An asterisk (*I corresponds to the M+’ radical molecular 
ion of a polyphenyl ether component from the diffusion pump 
oil; elemental composition C,,, HZ,O,; average calculated molecu- 
lar weight 446.50. 
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that represent a similar pattern to that observed in PD 
TOF/MS. 
To check the complete primary sequence of the free 
form of Braun’s lipoprotein the protein was cleaved 
with cyanogen bromide in formic acid as solvent (ex- 
periments that involved trifluoroacetic acid as solvent 
to prevent possible formylation of the resulting pep- 
tides yielded unsatisfactory results compared to formic 
acid). Due to the presence of two methionines in the 
amino acid sequence three cleavage products were 
expected, which include two water-soluble peptides as 
well as one water-insoluble peptide that corresponds 
to the N-terminal lipopeptide. Based especially on the 
solubility properties of the lipopeptide, the whole mix- 
ture was dissolved in the same solvent as that used for 
the intact lipoprotein for sample adsorption onto nitro- 
cellulose support. The resulting positive-ion PD mass 
spectrum exhibited all peptide fragments, which in- 
cluded the strongly hydrophobic lipopeptide (CNBr l), 
but with very low abundance and some singly and 
doubly formylated side reaction products (data not 
shown). Therefore the whole peptide mixture was sep- 
arated first into a water-insoluble fraction (that con- 
tained mainly the lipopeptide, CNBr 1) and a water- 
soluble fraction (that contained the other two peptides, 
CNBr 2 and CNBr 3) by a simple centrifugation proce- 
dure by using aqueous 0.1% trifluoroacetic acid as 
solvent. The pellet (the water-insoluble fraction) mainly 
contained the doubly formylated lipopeptide, as con- 
firmed by positive-ion I’D TOF/MS (see Figure 5). The 
soluble part that contained the remaining two cyanogen 
bromide-generated peptides was further purified and 
separated by reverse phase HPLC. Mainly nonformyl- 
ated peptides, but also traces of singly formylated 
products, were observed as individual LC peaks iden- 
tified by positive-ion PD TOF/MS (Figure 6 and Table 
3). Comparison of the calculated values for the 
cyanogen bromide peptides with the found values 
showed that only the [M + HI+ ion of the lipopeptide 
exhibited a significant mass shift of +56 u (Table 3). 
This shift corresponds most likely to a doubly for- 
mylated lipopeptide [M + HI+ ion, a common artefact 
of peptides and proteins cleaved with cyanogen bro- 
mide in the presence of a high percentage of formic 
acid as solvent [38, 421. Formylation of peptides nor- 
mally occurs first at the N-terminal end, but due to the 
fact that this lipopeptide is N-terminally blocked with 
a fatty acid moiety, formylation can take place only at 
the amino acid side chains of this peptide (e.g., serine, 
threonine, and lysine). The fragment ion m/z 3560.3 in 
Figure 5a, where the lipopeptide is adsorbed onto a 
nitrocellulose support, most likely corresponds to loss 
of the diglyceride moiety, which is not detected when 
the sample is adsorbed onto 9-anthroic acid matrix 
(Figure 5b) due to lower internal energy of desorbed- 
ionized sample molecules [31]. 
Abundant fragment ions correlated each with their 
primary sequence were detected during analyses of the 
internal lipoprotein sequence peptide CNBr 2 (Figure 
6a) and the C-terminal hexapeptide CNBr 3 (Figure 
Table 3. Molecular weight determination of the peptide fragments generated by cleavage of the free form of the outer membrane 
7-ku lipoprotein with cyanogen bromide as well as the by-products (e.g., formylation, hydrolysis of the C-terminal homoserine lactone) 
known to be present in such digests; the fragments were separated by reverse phase HPLC 
[M 4 HI-,‘[M + 2Hl**,‘[M + 3H13’ Primary sequence 
HPLC fraction CNBr average m/z values Amino acid of the CNBr 
number R, (min) fragment Calculated Found sequence peptide fragmenta 
Water-insoluble CNBr 1 4077.18/ I-)/ l-31 C*SSNAKIDQLSSDVQTLNAKV 
2039.09/ f-j/ DQLSNDVNAHsl 
1360.07 (-) 
Water-insoluble CNBr 1, 4133.20,’ 4133.2/ l-31 C*SSNAKIDQLSSDVQTLNAKV 
dlformylated 2067.10/ C-j/ DQLSNDVNAHsl 
1378.74 (-) (diformylated) 
1 (35.04) CNBr 3 766.92/ 766.8/ 53 -58 ATKYRK 
383.96 383.8 
2 (38.50) CNBr-3, 794.93/J 794.8/ 53 -58 ATKYRK (monoformylated) 
monoformylated 397.97 397.8 
3 (47.61) CNBr-2 2299.42/ 2298.7/ 32 -52 RSDVQAAKDDAARANQRLDN 
1 150.22/ 1150.1/ Hsl 
76.7.1 5 767.4 
4 (49.42) CNBr 2, 2327.43/ 2325.7/ 32 -52 RSDVQAAKDDAARANQRLDN 
monoformylated 1164.22 1163.9 Hsl (monoformylated) 
5 (49.42) CNBr 2, 2345.45/ 2344.7/ 32.52 RSDVQAAKDDAARANQRLDN 
monoformylated 1173.23 1 172.9/ Hse (monoformylated and 
and hydrolyzed hydrolyzed) 
aC* = S-[2.3-bis(acvloxy)-prnpyll-Nacylcystelne m/z values calculated for C*-contaning peptldes are based on a 16:0-l 6:0-18:l -major 
fatty acid composition of the lipid anchor Hsl corresponds to C-terminal homoserine lactone. Hse corresponds to C-terminal homoserine. 
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Table 4. Fragment ions of the cymogen bromide-generated peptide CNBr 2 observed in the 
positixx-Ion PD rna~s spectrum (compare Figure 6b); [M + H] - = 766.92 (talc.)” 
Peptide fragment m/z Value Mass dewation 
Ion type Calculated Found (Am) 
.-~ 
z,,/z, + 1 286.35/287.36 287.35 -1 .oo/ - 0.0 
Y2 
x2 
w3 
zg/z3 c 1 
Y3 
x3 
v‘l 
w4 
Zq/‘Zq + 1 
a,,/a, * 1 
Y4 
x4 
b, 
b, - H,O 
w5 
” 53 f “50 
*, 
z5,;zg + 1 
.- K 
V5 
a6ia6 t H 
x5 
6, 
Z6,!ZS * 1 
w6 
303.38 303.45 
329 38 329 33 
358.41 358.61 
449.53/450.54 450.33 
466.56 466.10 
492.56 492.35 
520.61 521.61* 
521.60 521.61* 
577 70/578.71 578.89 
592.71/593 73 593.67 
594.73 593.67 
620.73 620.41* 
620.73 620.41* 
638.74 638.67 
649.77 649.75 
662.81/664 78 664.18* 
663.80 664.18* 
678.81/679.82 679.16 
694 79 695.15* 
695.84 695.15* 
720.89,‘721 90 721.16* 
721.83 721.16* 
748.90 750.14* 
749.89/750 90 750.14* 
750.88 750.14* 
+0.07 
- 0.05 
-0.20 
+0.80,‘- 0.21 
- 0.46 
-0.21 
-1 .oo 
+0.01 
+1.19/- 0.18 
+0.96,‘- 0.06 
-1.06 
-0.32 
-0.32 
-0.07 
- 0.02 
+1.37/ - 0.60 
+0.38 
-0.35/J - 0.66 
f0.36 
- 0.69 
+0.27,’ - 0.74 
- 0.67 
+1.24 
+0.25/ - 0.76 
-0.74 
aAn asterisk (*I lndlcates possible peak overlapping of fragment 10”s of slmllar mass value due to 
lnsufflclent mass resolution of this time-of-flight Instrument 
6b). The fragment ions included both peptide back- 
bone as well as peptide side chain fragment ions classi- 
fied according to the modified Roepstorff-Fohlman 
nomenclature 146, 471 as earlier described by several 
groups for positive-ion I’D TOF/MS [48-631 (Tables 4 
and 5). 
Additionally, the C-terminal hexapeptide exhibited 
a peptide backbone rearrangement ion of type [b, + 
H,O]’ by loss of the C-terminal amino acid lysine (see 
Figure 6b). This rearrangement ion represents a frag- 
mentation type previously reported from high energy 
collision-induced dissociation (CID) spectra of alkali 
cationized peptides (e.g., [M + Li] ’ and [M + Na] + 1 
in three- and four-sector tandem instruments [M-67], 
as well as from low energy CID spectra of protonated 
peptides in sector-quadrupole hybrid tandem instru- 
ments [68]. It has not, to our knowledge, been reported 
previously from positive-ion I’D mass spectra of pep- 
tides. This type of fragment ion of either alkali- 
cationized or protonated peptides is especially helpful 
in identifying and confirming the C-terminal amino 
acid of a peptide. The peptide sequence requirements 
(at least a free COOH moiety at the C-terminal end) to 
observe such peptide rearrangement ions in CID spec- 
tra already have been discussed in the previously cited 
papers [ 64-681. 
Finally, an attempt was made to characterize the 
bound form of Braun’s lipoprotein, which means the 
free form of the Braun’s lipoprotein covalently linked 
to peptidoglycan monomers, dimers, and trimers as 
well as their corresponding mono-anhydro muramic 
acid derivatives, that are released after muramidase 
digestion of native peptidoglycan and differ in mass 
from the free form by roughly + 1000 u to appear in 
the mass range between m/z 8300 and 10,300. PD 
TOF/MS and MALDI TOF/MS analyses were tried 
with the same sample solvent and support/matrix 
materials used for the free form. Unfortunately, for 
unknown reasons no useful mass spectra could be 
obtained from this mixture of “lipoglycoproteins” by 
either desorption-ionization technique. Therefore, by 
digesting the bound form of Braun’s lipoprotein with 
pronase E, the complete protein part was hydrolyzed 
and resulted in a rather complex mixture of Lys-Arg- 
containing peptidoglycan monomers, dimers, and 
trimers as well as their corresponding mono-anhydro 
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derivatives. These components reflected all possible 
attachment sites of this lipoprotein to peptidoglycan. 
Separation of this mixture by reverse phase HPLC 
with subsequent identification of the fractions by 
positive- and negative-ion PD TOF,/MS showed at 
least seven different LysArg-containing peptidogly- 
can fragments. Isomeric mono-anhydro dimers and 
trimers were not separated sufficiently by this reverse 
phase HPLC system; therefore only isomeric mixtures 
were measured by I’D TOF/MS (Table 6). 
Figure 7 shows an example of the positive-ion 
PD mass spectra of muramidase-generated LyspArg- 
containing peptidoglycan trimer as well as its corre- 
sponding isomeric mixture of mono-anhydro trimers; 
the former and the latter differ in mass by 20 u. The 
spectra were obtained by using nitrocellulose support 
after application of a rinsing procedure with water to 
remove alkali cation contaminations. In contrast to 
LyssArg-containing dimers as well as trimers, which 
do not exhibit significant fragmentation in I’D 
TOF/MS, the corresponding LysArg-containing pep- 
tidoglycan monomer exhibits extensive fragmentation 
as discussed elsewhere [20]. Figure 8 shows an exam- 
ple of a LyssArg-containing peptidoglycan dimer 
Tri-TripLys Arg analyzed by positive-ion MALDI 
TOF/MS without any rinsing procedure. The absence 
of any sodium or potassium adduct ion formation 
demonstrates the tolerance of this technique to alkali 
contaminants. The small peak [M, + HI+ at m/z 2080, 
observed in addition to the [M, + HI+ peak of 
Tri-Tri-Lyss Arg (m/z 20091, corresponds to traces of 
TetraaTri-LyspArg that elute next to the former com- 
pound and are separated by f71 u. Interestingly, 
Lys-Arg-free peptidoglycan fragments (that is, pepti- 
doglycan fragments not covalently linked to lipopro- 
tein) yield abundant alkali metal adduct ions in their 
positive-ion MALDI mass spectra; protonated 
molecules are absent or of low abundance due to the 
absence of any strong protonation site in these 
molecules [ 181. 
Table 5. Fragment ions ot the cl anc~s:lw bromide released ptytldtx C-NBr 3 observed in the positive-ion PD mass spectrum 
(compare Figure 6a1, [M + H] - == 2299 42 (talc.)” 
Peptlde 
fragment m/z Value 
Ion type Calculated Found 
4 200.26 200.46 
ada, + 1 216.26/21727 21615 
CZ 261 30 261 09 
4 28734 28753 
a3/a3 + 1 331.35/33236 331 52 
4 416.46 416.79 
a4/a4 + 1 430.48/431.49 43074 
4 501.56 501 86 
a5/a5 + 1 558.61/559.62 55878 
b, 586.62 58638 
as/a6 + 1 629.69/630.70 629.63 
be 65770 657.45 
a7/a7 + 1 700.77/701.78 700.71 
b, 728.78 728.68 
4s 771.85 771.90 
as/a8 - 1 828.95/829.96 829.04 
4 900.03 900.13 
YS 914.95 913.95 
ada, + 1 944.04/945.05 944.04 
b, 972.05 971.88 
d 10 101511 101502 
a,o/a,, I 1 1059 12/1060.13 1060.32 
b 10 108713 108657 
x3 1097.13 109735 
WlO 1126.17 112705 
YlO 1142.22 114097 
a,,/a,,+ 1 1201.28/1202.29 1201.19 
x11 1239.29 123960 
"12 1267.34 126771 
deviation 
(Am) 
Peptlde 
fragment 
Ion type 
m/z Value 
Calculated Found 
+0.20 
-0 ll,'- 1.12 
-021 
+o 19 
+O 17j- 0.84 
co.35 
+026/ - 0.75 
+0.30 
-0 17/'- 0.84 
-024 
-0.06/ - 1.07 
-0.25 
-006/- 1.07 
-0 10 
-0.05 
-009/- 0.91 
-co10 
~ 1 .oo 
o/- 1.01 
f0.83 
- 0.09 
-1.20;+ 0 19 
-0.56 
+0.22 
-0.12 
to.75 
-0.09,'- 1 10 
to.31 
+0.37 
d 
alj;;al,: + 1 
b 13 
z 13i.713 + 1 
x14 
w14 
d 15 
a 15' 1a,5 -1 
v14 
b 15 
214/214 -1 
z 151215 + 1 
a,,/a,, - 1 
x15 
X16 
VI 7 
a171alJ -1 
x17 
d 18 
Y18 
a18, ia,8 + 1 
X18 
d 19 
x19 
"20 
~20,/~20 - 1 
a20ia20 -1 
-COOH 
1272.36 1272.72 
1357.47/1358.48 1357.56 
1385.48 1382.48 
1426.44,'1427.45 1427.44 
146947 1469.08 
1498.51 1498.20* 
1499.63 1498.20* 
1542.65/1543.66 1543.39 
1570.66 1569.69* 
1571.65 1569.69* 
1597.64/l 598.65 1597.30 
162570/1626.71 1623.99 
1671.77/1672.78 1671.79 
1696.77 1697.20 
1739.80 173901 
1767.85 1766.15 
1827.95/1828.96 1827.18 
1867.93 1865.85 
1901.05 1898.43 
1941.07 1940.18* 
194111/1941.12 1940.18* 
1967.06 1967.90 
2012.19 2012.34 
2082.15 2080.26 
2110.21 2111.91 
2126.20/2127.21 2126.43 
2170.30,'2171.31 2170.72 
2254.41 2254.06 
Mass 
deviation 
(Am) 
+0.36 
to.o9/ - 0.92 
-3.00 
+1.00/- 0.01 
-0.39 
-0.31 
-0.43 
+0.74/- 0.27 
-0.97 
- 1.96 
-0.34/- 1.35 
-1.71/2.72 
+0.02/+ 0.99 
+0.57 
-0.79 
-1.70 
-0.77/- 1.78 
-2.08 
-2.62 
- 0.99 
-0.93/- 194 
+0.84 
+0.15 
-1.80 
+1.70 
+0.23/- 0.78 
+0.52/- 0.59 
-0.35 
aAn asterisk (*I lndlcate possible peak overlapplng of fragment 10”s of s~mllar mass value due to lnsufficlent mass resolution of this 
tame-of-flight unstrument 
Table 6. Molecular weight determma~ion of Lys-Arg-containing peptidoglycan fragments released by pronase E digestion from the 
bound form of Braun’s lipoprottln, separated by reverse phase HPLC and identified by positive- and negative-ion I’D TOF/MS; 
in the case of anhydro-peptldoglycan dimers and trlmers all structures known to be present are listed (based on the work of 
Glauner and co-workers II 7. 181) because these isomers were not separated by this reverse phase HPLC system 
HPLC 
[M + HI /[M + 2H12 [M - HI- 
Common nomenclature 
fraction 
number average m/z values average m/z values 
(type of peptide side chain cross linkage; only with dimers and trimers) 
chemxal structure of monomers/isomeric structures 
R, (min) Calculated Found Calculated Found In case of anhvdro dlmers and trimers 
1 (49.91) 1156.23 11563 1154.11 1154.3 Tri + Lys-Arg, 
578.62 578 7 GlcNAc --f MurNAc + L-Ala -j y-D-Glu-L(D)-A2pm + c-Lys +- Arg 
2 (73.31) 2009.08 2008.4 2007.07 2007.2 Trl --f Trl -Lys -Arg. (L-A,pm + D-A,pm) 
1005.05 1005.1 
3 (80.49) 2080 16 2080 1 2078 15 1986.0 Tetra -) Trl -Lysm-Arg, (D-Ala * D -A,pm) 
1040.58 1041 0 
4 (SO. 16) 3004.10 3004.3 3002.07 3001 .S Tetra --* Tetra + Trt -Lys -Arg, (D-Ala -+ D -A,pm, D-Ala + D -A,pm) 
1502.55 1052.6 
5 (I 02.77) 1989.05 19906 1987.04 1987.4 Trl -+ Trl -Lys -Arg (Anh), (L-A,pm + D -A,pm). 
995.03 995.1 Trl(Anh) 4 Tri -Lys -Arg and Tri + Tri -Lys -Arg(Anh) 
6 (108.77) 2060.13 2060 0 2058.1 1 2056.8 Tetra ---f Trl -Lys-Arg(Anh), (D-Ala + D -A,pm), 
1030.57 1030 7 Tetra(Anh) + Tn -Lys -Arg and Tetra + Tri -Lys -Arg(Anh) 
7 (1 10.03) 2984.06 2984 2 2982.04 2981.2 Tetra + Tetra ---* Tri -Lys -Arg(Anh), (D -Ala --) D -A,pm, 
D Ala --t D-A,pm), 
1492.53 1492 8 Tetra(Anh) + Tetra -+ Trl -Lys -Arg, Tetra -j Tetra(Anh) + 
Trl -Lys -Arg and 
Tetra -+ Tetra + Trl -Lys -Arg(Anh) 
The present work demonstrates a strategy for the 
rapid characterization of a strongly hydrophobic, 
water-insoluble lipoprotein bv time-of-flight mass 
spectrometry. Significant structural information follow- 
ing appropriate selection of individual analyte sol- 
vent-support/matrix combinations for different 
classes of compounds was obtained by positive- and 
negative-ion I’D TOF/MS and positive-ion MALDI 
TOF/MS. Whereas pure peptides (CNBr 2 and CNBr 
3) and glycopeptides (Lys-Arg-containing peptidogly- 
can fragments) yielded satisfactory results by using the 
nitrocellulose adsorption technique as originally de- 
scribed by Jonsson et al. 1251, other lipid-containing 
samples failed. For the chloroform-soluble lipid anchor 
we adapted our recently described sample preparation 
technique for lipids and glycolipids [20, 33-351 by 
using 3-(3-pyridyl) acrylic acid as matrix, thereby tol- 
erating strongly lipophilic analyte solvents. Finally, for 
the water-insoluble free form of Braun’s lipoprotein 
and for the cyanogen bromide cleavage peptide ClCBr 
1 (the lipopeptide), either nitrocellulose support or 
9-anthroic acid or 3-(3-indolyl) acrylic acid matrix 
yielded satisfactory results by using formic acid: 
water:methanol:2-propanol (5:15:30:40) as analyte sol- 
vent. Additionally, for most compounds investigated 
(except for the free lipid anchor), MALDI TOF/MS 
gave better sensitivity and comparable data in terms of 
information content and mass spectrometric resolution 
if appropriate matrices were selected (sinapinic acid 
for the lipoprotein and 2,5dihydroxybenzoic acid for 
glycopeptides). 
104%. b 
[M+Hj+ 2984.2 
1 
1 
M/Z 
Figure 7. Positive-ion PD mass spectra of muramidase-released 
Lys-Arg-containing peptidoglycan trimers from the bound form 
of Braun’s lipoprotein that represents (a) LC fraction 4, the trimer 
I’ertapTetra-Tri-Lys-Arg, and (b) LC fraction 7, the trimer 
Tertn-Tetra-Tri-Lys-Arg (Anh), both adsorbed onto nitrocellu- 
lose support. For the corresponding LC fraction numbers 4 and 7, 
comparc with Table 6. 
M+HI+ 
Figure 8. Positive-ion MALDI mass zpectrum of the muram,- 
dase-released Lps--Arg-contaimng peptldoglycan dimer from the 
bound form of Braun’s lipoprotein that represents LC fraction 2, 
the peptidoglycan dimer Tri TrimLy5 Arg denoted as [M, + 
HI’. The small peak denoted as [M, + HI- corresponds to 
traces of the peptidoglycan dimer I‘etra-Tri-LvmArg as an m- 
purity of the next LC fraction. For the corresponding LC fraction 
numbers 2 and 3, compare with Table 6. 
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